Willingdon Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$12K Hold
54
﹤0.01% 201
2019
Q4
$16K Sell
54
-10
-16% -$2.75K ﹤0.01% 227
2019
Q3
$15K Buy
64
+10
+19% +$2.74K ﹤0.01% 227
2019
Q2
$15K Buy
+54
New +$14.8K ﹤0.01% 216
2018
Q4
Sell
-26
Closed -$7K 357
2018
Q3
$7K Buy
+26
New +$6.75K ﹤0.01% 310

Other funds holding ELV

Willingdon Wealth Management's ELV Position: Q1 2020 in Review

Willingdon Wealth Management held its Elevance Health (ELV) position steady in Q1 2020 at 54 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #201.

Willingdon Wealth Management first reported a position in ELV in Q3 2018 and has held it in 5 quarters since. The position peaked at $16K in Q4 2019. 1,051 funds tracked by Wall St. Rank hold ELV as of Q1 2020.

  • Willingdon Wealth Management held 54 shares of Elevance Health worth $12K as of Q1 2020.
  • Willingdon Wealth Management left its Elevance Health share count unchanged in Q1 2020.
  • Elevance Health made up ﹤0.01% of Willingdon Wealth Management's portfolio in Q1 2020, its #201 holding.
  • Willingdon Wealth Management first reported a position in Elevance Health in Q3 2018 and has held it in 5 quarters since.
  • Willingdon Wealth Management's Elevance Health position peaked at $16K in Q4 2019.
  • 1,051 funds tracked by Wall St. Rank held Elevance Health as of Q1 2020.

Based on Willingdon Wealth Management's 13F filing for Q1 2020, filed 21 Apr 2020.